Skip to main content
Retour
Watch Compare

Aspira Women's Health Inc.

Qualité des données : 100%
AWHL
OTC Manufacturing Chemicals
0,30 €
▼ 0,01 € (-3,28%)
Cap. Boursière: 13,05 M
Prix
0,30 €
Cap. Boursière
13,05 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Revenue declined -52,63% annually over 5 years
Negative free cash flow of -7,05 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 38,80%
Capital efficient — spends only 4,66% of revenue on capex

Croissance

Revenue Growth (5Y)
-52,63%
En dessous de la moyenne du secteur (1,82%)
Revenue (1Y)-91,43%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROIC-265,95%
Net Margin-3725,95%
Op. Margin-2307,00%

Sécurité

Debt / Equity
N/A
Current Ratio1,39
Interest Coverage-193,00

Valorisation

PE (TTM)
-1,02
Au-dessus de la moyenne du secteur (-1,47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -1,0 -1,5
P/B — 1,6
ROE % — -53,3
Net Margin % -3726,0 -41,5
Rev Growth 5Y % -52,6 1,8
D/E — 0,3

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Aucune estimation prévisionnelle disponible

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42024 -0,22 € -0,09 € +61,4%
Q32024 -0,28 € -0,24 € +13,7%
Q22024 -0,33 € -0,32 € +1,8%
Q12024 -0,32 € -0,38 € -19,2%

All Fundamental Metrics
Growth
Revenue Growth (1Y) -91,43% Revenue Growth (3Y) -80,64%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -52,63% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 343 000,0 Net Income (TTM) -12,78 M
ROE N/A ROA -208,99%
Gross Margin 1724,49% Operating Margin -2307,00%
Net Margin -3725,95% Free Cash Flow (TTM) -7,05 M
ROIC -265,95% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1,39
Interest Coverage -193,00 Asset Turnover 0,06
Working Capital 1,63 M Tangible Book Value -4,69 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,02 Forward P/E N/A
P/B Ratio N/A P/S Ratio 38,05
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -53,98%
Market Cap 13,05 M Enterprise Value 11,19 M
Per Share
EPS (Diluted TTM) -0,37 Revenue / Share 0,01
FCF / Share -0,16 OCF / Share -0,16
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 4,66% FCF Conversion 55,13%
SBC-Adj. FCF -7,56 M Growth Momentum -38,80

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 343 000,0 4,00 M 9,15 M 8,18 M 6,81 M
Net Income -12,78 M -13,09 M -16,69 M -27,17 M -31,66 M
EPS (Diluted) -0,37 -0,93 -1,81 -0,23 -0,28
Gross Profit 5,92 M 5,48 M 5,26 M 4,32 M 3,06 M
Operating Income -7,91 M -16,28 M -18,85 M -32,77 M -32,60 M
EBITDA — — — — —
R&D Expenses 2,88 M 3,27 M 4,04 M 5,95 M 5,31 M
SG&A Expenses — — — — —
D&A — — 199 000,0 264 000,0 302 000,0
Interest Expense -41 000,0 -33 000,0 48 000,0 17 000,0 -48 000,0
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 5,46 M 5,49 M 6,26 M 17,37 M 41,08 M
Total Liabilities 12,39 M 8,05 M 8,63 M 10,64 M 10,91 M
Shareholders' Equity -6,93 M -2,56 M -2,37 M 6,73 M 30,17 M
Total Debt 1,77 M 2,12 M 2,27 M 3,48 M 3,70 M
Cash & Equivalents 1,76 M 1,77 M 2,60 M 13,31 M 37,18 M
Current Assets 4,06 M 4,18 M 5,28 M 16,31 M 40,01 M
Current Liabilities 3,47 M 5,47 M 5,12 M 5,78 M 7,84 M